鈴木 翔 (スズキ シヨウ)

SUZUKI Sho

写真a

所属

医学部 附属病院 卒後臨床研修センター

職名

助教

外部リンク

 

論文 【 表示 / 非表示

  • A novel endoscopic submucosal dissection training model using skinned chicken meat with gel.

    Suzuki S, Kawakami H, Miike T, Ishikawa Y, Hirata T, Ichinari N, Komura A

    Endoscopy   2020年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1055/a-1287-8567

    PubMed

  • Complete Remission of Colon Cancer with Ipilimumab Monotherapy.

    Suzuki S, Kawakami H, Miike T, Yamamoto S

    Internal medicine (Tokyo, Japan)   2020年10月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:一般社団法人 日本内科学会  

    DOI: 10.2169/internalmedicine.6024-20

    PubMed

  • Single Rectal Neuroendocrine Tumor Associated with Multiple Endocrine Cell Micronests

    Suzuki S., Kawakami H., Miike T., Yamamoto S., Abe H., Shimoda K., Ashizuka S., Inatsu H., Kubota Y., Ban T., Yorita K., Kataoka H.

    Internal Medicine   59 ( 5 )   619 - 623   2020年3月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Internal Medicine  

    © 2020 Japanese Society of Internal Medicine. All rights reserved. Although a few reports of neuroendocrine tumor (NET) in the stomach or appendix with surrounding micronests have been published, cases of rectal NET are rare. We herein report a unique case of a patient with single rectal NET treated endoscopically. A pathological examination revealed multiple endocrine cell micronests (ECMs) in the submucosal layer around the main NET lesion. Neither lymph node metastasis nor distant metastasis in computed tomography was observed six years after the treatment. Because case reports of multiple ECM are very rare, the significance of malignancy is unclear. It therefore appears to be necessary to accumulate similar cases.

    DOI: 10.2169/internalmedicine.3582-19

    Scopus

    PubMed

  • Inhibitory effect of lidocaine on colonic spasm during colonoscopy: A multicenter double-blind, randomized controlled trial (with a video)

    Nemoto D., Suzuki S., Mori H., Katsuki S., Iwaki T., Aizawa M., Takeuchi Y., Uraoka T., Matsuda T., Fujita T., Hewett D.G., Togashi K.

    Gastroenterological Endoscopy   62 ( 2 )   210 - 219   2020年2月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Gastroenterological Endoscopy  

    © 2020 Japan Gastroenterological Endoscopy Society. All rights reserved. Objectives: Colonic spasm can interfere with colonoscopy, but antispasmodic agents can cause complications. This study aimed to assess the inhibitory effect of topical lidocaine compared with a placebo control. Methods: In five tertiary-care hospitals in Japan, 128 patients requiring endoscopic resection of a colorectal lesion were enrolled and randomly and double-blindly allocated to colonoscopy with topical administration of 2% lidocaine solution 20mL (LID, n=64) or normal saline 20mL (control, n=64). During colonoscopy, the assigned solution was applied with a spray catheter near the lesion and the area was observed for three minutes. Primary endpoint was the inhibitory effect at three time-points (1, 2 and 3 minutes after dispersion), using a three-point scale (excellent, fair, poor). Secondary endpoints were rebound spasm and adverse events. All endpoints were scored in real time. Serum lidocaine levels were measured in 32 patients (LID 16, control 16). Results: There were no significant differences between groups in patient demographics. At all time-points, the proportion of patients with “excellent” scores was greater in LID group than control group, with significant differences observed at 2 minutes (p=0.02) and 3 minutes (p=0.02). In LID group, the rate of “excellent” scores increased by 12.5% at 2 minutes and was maintained at 3 minutes. Rebound spasm did not occur in LID group, compared with 15.6% of control group (p=0.001). There were no adverse events in LID group. All serum lidocaine levels were below detectable levels. Conclusions: Topical lidocaine is an effective and safe method for suppressing colorectal spasm during colonoscopy (UMIN000024733).

    DOI: 10.11280/gee.62.210

    Scopus

  • Long-term outcomes after endoscopic submucosal dissection for differentiated-type early gastric cancer that fulfilled expanded indication criteria: A prospective cohort study

    Shichijo S., Uedo N., Kanesaka T., Ohta T., Nakagawa K., Shimamoto Y., Ohmori M., Arao M., Iwatsubo T., Suzuki S., Matsuno K., Iwagami H., Inoue S., Matsuura N., Maekawa A., Nakahira H., Yamamoto S., Takeuchi Y., Higashino K., Ishihara R., Fukui K., Ito Y., Narahara H., Ishiguro S., Iishi H.

    Journal of Gastroenterology and Hepatology (Australia)   2020年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Gastroenterology and Hepatology (Australia)  

    © 2020 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd Background and Aim: Endoscopic resection for early gastric cancer (EGC) is widely performed. However, there is still a paucity of strong evidence regarding long-term outcomes after endoscopic submucosal dissection (ESD) for the expanded indication criteria of the Japanese guidelines (ver. 2010). Methods: Endoscopic submucosal dissection was performed in patients with EGC that met the expanded indication criteria: (i) cT1a, differentiated-type EGC of 2 to 5 cm, ulcer negative or (ii) cT1a, differentiated-type EGC of ≤3 cm, ulcer positive. Patients whose pathological examination fulfilled the curative resection criteria were then enrolled in this cohort study: negative vertical margin, negative lymphovascular invasion, and (i) pT1a, differentiated-type, and ulcer negative; (ii) pT1a, differentiated-type, ≤3 cm, and ulcer positive; or (iii) pT1b1 (<500-μm submucosal invasion), differentiated-type, and ≤3 cm. Patients with only a positive horizontal margin as a noncurative factor were included for follow-up. Results: From September 2003 to February 2012, a total of 356 patients underwent ESD, and 214 were enrolled in the survival analysis. One hundred twenty patients (56%) had >2 cm in diameter and ulcer-negative lesions, and 94 (44%) had ≤3 cm and ulcer-positive lesions. The vital status at 5 years after ESD was confirmed in all (100%) patients. No local or metastatic recurrence was detected; however, 26 metachronous gastric cancers developed, and 1 patient died of metachronous gastric cancer. The 5-year disease-specific and overall survival rates were 99.5% (95% confidence interval [CI], 97.2%–100%) and 93.9% (95% CI, 89.8%–96.4%), respectively. Conclusion: ESD for EGC that fulfills the expanded criteria is feasible and shows favorable long-term outcomes.

    DOI: 10.1111/jgh.15182

    Scopus

全件表示 >>

書籍等出版物 【 表示 / 非表示

  • H. pylori未感染胃上皮性腫瘍の臨床的特徴

    鈴木 翔,上堂 文也,河上 洋,石原 立( 担当: 共著)

    医学書院  2020年7月 

     詳細を見る

    総ページ数:981-987   担当ページ:981-987   記述言語:日本語 著書種別:一般書・啓蒙書

MISC 【 表示 / 非表示

講演・口頭発表等 【 表示 / 非表示

  • 高齢者における食道ESD非高齢者同様に安全である

    鈴木 翔, 三池 忠, 貴島 翔子, 米澤 瑛美, 坂元 一樹  平田 智也, 野田 貴穂, 安倍 弘生, 田原 良博, 山本 章二朗, 河上 洋

    第 98 回消化器内視鏡学会 

     詳細を見る

    開催年月日: 2019年11月21日

    記述言語:日本語   会議種別:口頭発表(一般)  

  • Inhibitory Effect of Lidocaine on Colonic Spasm during Colonoscopy: A Multicenter Double-Blind, Randomized Controlled Trial

    Sho Suzuki, Daiki Nemoto, Hideki Mori, Shinichi Katsuki , Tomoyuki Iwaki, Masato Aizawa, Yoji Takeuchi, Toshio Uraoka, Tomoki Matsuda, Tomoki Fujita, Kazutomo Togashi

    第95回日本消化器内視鏡学会総会  (東京都)  東邦大学医療センター大森病院

     詳細を見る

    開催年月日: 2018年5月11日

    記述言語:英語   会議種別:シンポジウム・ワークショップ パネル(公募)  

    開催地:東京都